Abstract
Tofacitinib is contraindicated in pregnancy. We present a patient with ulcerative colitis on tofacitinib who had an unplanned pregnancy. Tofacitinib was ceased, switched to vedolizumab, and she gave birth to a healthy newborn at term. Case reports of reassuring outcomes provide real-world data that assists decision-making for future patients.
| Original language | English |
|---|---|
| Article number | e8764 |
| Pages (from-to) | 1-4 |
| Number of pages | 4 |
| Journal | Clinical Case Reports |
| Volume | 12 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 12 Apr 2024 |
Bibliographical note
Copyright the Author(s) 2024. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.Keywords
- Janus kinase inhibitors
- Case report
- Inflammatory bowel diseases
- Pregnancy
- Tofacitinib
- Ulcerative colitis
Fingerprint
Dive into the research topics of 'First-trimester exposure to tofacitinib in ulcerative colitis: a case report of a healthy newborn and literature review'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver